Literature DB >> 32741211

Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study.

Clare Oliver-Williams1,2, Ditte Vassard3, Anja Pinborg4, Lone Schmidt3.   

Abstract

Entities:  

Year:  2020        PMID： 32741211     DOI： 10.1177/2047487320939674

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  9 in total

1.  A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification.

Authors:  Olatokunbo Osibogun; Oluseye Ogunmoroti; Olamide B Kolade; Allison G Hays; Victor Okunrintemi; Anum S Minhas; Martha Gulati; Erin D Michos
Journal:  J Womens Health (Larchmt)       Date:  2022-05-16       Impact factor: 3.017

Review 2.  Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk.

Authors:  Srdan Pandurevic; Djuro Macut; Flaminia Fanelli; Uberto Pagotto; Alessandra Gambineri
Journal:  Biomolecules       Date:  2021-09-12

Review 3.  Coronary Artery Disease in Women: A Comprehensive Appraisal.

Authors:  Nili Schamroth Pravda; Orith Karny-Rahkovich; Arthur Shiyovich; Miri Schamroth Pravda; Naomi Rapeport; Hana Vaknin-Assa; Alon Eisen; Ran Kornowski; Avital Porter
Journal:  J Clin Med       Date:  2021-10-12       Impact factor: 4.964

4.  Evidence From Men for Ovary-independent Effects of Genetic Risk Factors for Polycystic Ovary Syndrome.

Authors:  Jia Zhu; Natàlia Pujol-Gualdo; Laura B L Wittemans; Cecilia M Lindgren; Triin Laisk; Joel N Hirschhorn; Yee-Ming Chan
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 6.134

5.  Trends, Predictors, and Outcomes of Cardiovascular Complications Associated With Polycystic Ovary Syndrome During Delivery Hospitalizations: A National Inpatient Sample Analysis (2002-2019).

Authors:  Salman Zahid; Muhammad Zia Khan; Smitha Gowda; Nadeen N Faza; Michael C Honigberg; Arthur Jason Vaught; Carolyn Guan; Anum S Minhas; Erin D Michos
Journal:  J Am Heart Assoc       Date:  2022-06-16       Impact factor: 6.106

Review 6.  Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.

Authors:  Kok-Min Seow; Yi-Wen Chang; Kuo-Hu Chen; Chi-Chang Juan; Chen-Yu Huang; Li-Te Lin; Kuan-Hao Tsui; Yi-Jen Chen; Wen-Ling Lee; Peng-Hui Wang
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

7.  Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.

Authors:  Praveenkumar Devarbhavi; Lata Telang; Basavaraj Vastrad; Anandkumar Tengli; Chanabasayya Vastrad; Iranna Kotturshetti
Journal:  Reprod Biol Endocrinol       Date:  2021-02-23       Impact factor: 5.211

Review 8.  Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor.

Authors:  Jelena Marinkovic-Radosevic; Maja Cigrovski Berkovic; Egon Kruezi; Ines Bilic-Curcic; Anna Mrzljak
Journal:  World J Diabetes       Date:  2021-07-15

9.  Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome.

Authors:  P Falcetta; E Benelli; A Molinaro; C Di Cosmo; B Bagattini; S Del Ghianda; G Salvetti; E Fiore; E Pucci; F Fruzzetti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2021-06-05       Impact factor: 4.256
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.